Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q1 2018 (← Previous) (Next →)

Filing Date: May 15, 2018

Total Value: $2.338B (100.0% shares, 0.0% debt)

Holdings (36)

— ABIOMED INC 16.8%
Value $392M Shares 1,346,660 Share Price $290.99 Est. Cost/Share $32.04 Unrealized @ Report Date —
— CLOVIS ONCOLOGY INC 8.9%
Value $209M Shares 3,955,660 Share Price $52.80 Est. Cost/Share $54.18 Unrealized @ Report Date —
BMRN BIOMARIN PHARMACEUTICAL INC 8.8%
Value $206M Shares 2,545,482 Share Price $81.07 * Est. Cost/Share $79.79 Unrealized @ Report Date +7.6%
UTHR UNITED THERAPEUTICS CORP DEL 7.8%
Value $182M Shares 1,622,631 Share Price $112.36 * Est. Cost/Share $88.73 Unrealized @ Report Date +43.2%
INSM INSMED INC 6.9%
Value $161M Shares 7,159,590 Share Price $22.52 * Est. Cost/Share $16.67 Unrealized @ Report Date +57.8%
— SAGE THERAPEUTICS INC 5.6%
Value $132M Shares 818,331 Share Price $161.07 Est. Cost/Share $46.14 Unrealized @ Report Date —
— ALEXION PHARMACEUTICALS INC 5.4%
Value $127M Shares 1,135,845 Share Price $111.46 Est. Cost/Share $120.92 Unrealized @ Report Date —
— EPIZYME INC 5.2%
Value $122M Shares 6,895,075 Share Price $17.75 Est. Cost/Share $15.12 Unrealized @ Report Date —
FOLD AMICUS THERAPEUTICS INC 4.0%
Value $92.46M Shares 6,147,829 Share Price $15.04 Est. Cost/Share $6.44 Unrealized @ Report Date +136.3%
— IMMUNOMEDICS INC 3.0%
Value $70.07M Shares 4,796,008 Share Price $14.61 Est. Cost/Share $11.54 Unrealized @ Report Date —
VNDA VANDA PHARMACEUTICALS INC 3.0%
Value $70.02M Shares 4,155,670 Share Price $16.85 Est. Cost/Share $8.70 Unrealized @ Report Date +92.3%
— AMAG PHARMACEUTICALS INC 2.9%
Value $67.32M Shares 3,340,806 Share Price $20.15 Est. Cost/Share $29.37 Unrealized @ Report Date —
ALGN ALIGN TECHNOLOGY INC 2.3%
Value $54.92M Shares 218,707 Share Price $251.13 * Est. Cost/Share $98.66 Unrealized @ Report Date +160.3%
— WRIGHT MED GROUP N V 2.3%
Value $54.61M Shares 2,752,294 Share Price $19.84 Est. Cost/Share $23.42 Unrealized @ Report Date —
STAA STAAR SURGICAL CO 2.2%
Value $52.03M Shares 3,515,385 Share Price $14.80 * Est. Cost/Share $8.00 Unrealized @ Report Date +95.2%
— KARYOPHARM THERAPEUTICS INC 2.1%
Value $49.38M Shares 3,679,978 Share Price $13.42 Est. Cost/Share $19.34 Unrealized @ Report Date —
— AIMMUNE THERAPEUTICS INC 1.8%
Value $43.18M Shares 1,356,514 Share Price $31.83 Est. Cost/Share $23.73 Unrealized @ Report Date —
PRTA PROTHENA CORP PLC 1.7%
Value $40.43M Shares 1,101,338 Share Price $36.71 Est. Cost/Share $32.98 Unrealized @ Report Date +10.3%
ACAD ACADIA PHARMACEUTICALS INC 1.6%
Value $37.09M Shares 1,650,780 Share Price $22.47 * Est. Cost/Share $29.82 Unrealized @ Report Date -7.2%
— CELGENE CORP 1.4%
Value $33.82M Shares 379,140 Share Price $89.21 Est. Cost/Share $96.18 Unrealized @ Report Date —
— MOMENTA PHARMACEUTICALS INC 1.4%
Value $33.22M Shares 1,830,435 Share Price $18.15 Est. Cost/Share $14.12 Unrealized @ Report Date —
— SHIRE PLC 1.2%
Value $28.56M Shares 191,200 Share Price $149.39 Est. Cost/Share $197.13 Unrealized @ Report Date —
— ALDER BIOPHARMACEUTICALS INC 1.0%
Value $23.49M Shares 1,849,832 Share Price $12.70 Est. Cost/Share $11.48 Unrealized @ Report Date —
— RIGEL PHARMACEUTICALS INC 0.6%
Value $14.04M Shares 3,966,087 Share Price $3.54 Est. Cost/Share $3.40 Unrealized @ Report Date —
GILD GILEAD SCIENCES INC 0.6%
Value $13.26M Shares 175,900 Share Price $75.39 * Est. Cost/Share $62.02 Unrealized @ Report Date -5.0%
EXAS EXACT SCIENCES CORP 0.5%
Value $12.61M Shares 312,719 Share Price $40.33 * Est. Cost/Share $13.61 Unrealized @ Report Date +258.3%
— DICERNA PHARMACEUTICALS INC 0.2%
Value $4.789M Shares 500,913 Share Price $9.56 Est. Cost/Share $5.39 Unrealized @ Report Date —
— SUNESIS PHARMACEUTICALS INC 0.1%
Value $3.162M Shares 1,162,473 Share Price $2.72 Est. Cost/Share $4.37 Unrealized @ Report Date —
— ALIMERA SCIENCES INC 0.1%
Value $3.104M Shares 3,013,793 Share Price $1.03 Est. Cost/Share $4.88 Unrealized @ Report Date —
— ZOGENIX INC 0.1%
Value $1.181M Shares 29,500 Share Price $40.03 Est. Cost/Share $13.36 Unrealized @ Report Date —
— IDERA PHARMACEUTICALS INC 0.0%
Value $1.134M Shares 616,355 Share Price $1.84 Est. Cost/Share $3.70 Unrealized @ Report Date —
CYTK CYTOKINETICS INC 0.0%
Value $891K Shares 123,686 Share Price $7.20 * Est. Cost/Share $6.71 Unrealized @ Report Date +27.7%
— HISTOGENICS CORP 0.0%
Value $833K Shares 302,922 Share Price $2.75 Est. Cost/Share $11.00 Unrealized @ Report Date —
— TREVENA INC 0.0%
Value $560K Shares 341,300 Share Price $1.64 Est. Cost/Share $2.30 Unrealized @ Report Date —
— SOPHIRIS BIO INC 0.0%
Value $496K Shares 247,000 Share Price $2.01 Est. Cost/Share $2.60 Unrealized @ Report Date —
— MELINTA THERAPEUTICS INC 0.0%
Value $375K Shares 50,689 Share Price $7.40 Est. Cost/Share $15.80 Unrealized @ Report Date —